For research use only
| Cat No. | ABC-SC0241 |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Diabetes (mellitus) |
| Storage | Liquid Nitrogen |
Utilize HighQC™ Human Induced Pluripotent Stem Cells, From Diabetes (mellitus) for disease modeling, drug discovery, and regenerative therapy development.
HighQC™ Human Induced Pluripotent Stem Cells, From Diabetes (mellitus) are derived from patients with Diabetes Mellitus. These cells display classic pluripotent stem cell features, including a high nucleus-to-cytoplasm ratio, prominent nucleoli, and formation of tightly packed colonies under feeder-free culture conditions with optimized defined media. These cells are generated by transducing four transcription factors, including OCT4, SOX2, KLF4, and c-MYC. These cells retain the capacity to differentiate into cell types of all three germ layers—ectoderm, mesoderm, and endoderm—under directed differentiation protocols. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ Human Induced Pluripotent Stem Cells, From Diabetes (Mellitus), Human iPSC-DM, hIPSC-DM, Human Induced Pluripotent Stem Cells Diabetes |
| Species | Human |
| Cat.No | ABC-SC0241 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Diabetes (mellitus) |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ Human Induced Pluripotent Stem Cells, From Diabetes (mellitus) serve as a platform for diabetes research and therapeutic development. These cells enable the generation of pancreatic beta-like cells in vitro, providing a relevant model to study the cellular and molecular mechanisms underlying diabetes, including insulin production and secretion defects. Researchers can use these cells to investigate disease progression, beta cell dysfunction, and the impact of genetic and environmental factors. These cells include Diabetes mellitus human iPSC line, Diabetic patient-derived iPSCs, and Diabetes disease modeling stem cells, supporting disease-specific modeling and mechanistic studies in diabetes research.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).